10-K.Info (Beta Test) Courtesy of Short Sands, LLC | ||||||||||||||
| ||||||||||||||
|
10-K.Info (Beta Test) Courtesy of Short Sands, LLC | |||
JOHNSON & JOHNSON | |||
Ticker: JNJ Fiscal Year: 2011 | |||
Consolidated Statements of Earnings | |||
Period Ending Jan 1, 2012 10-K (Filed: Feb 23, 2012) | |||
| (In Millions, except shares in Thousands) | |||
| 12 Months Ended | 12 Months Ended | 12 Months Ended | |
| Jan 1, 2012 | Jan 2, 2011 | Jan 3, 2010 | |
| Sales to customers | $ 65,030 | 61,587 | 61,897 |
| Cost of products sold | 20,360 | 18,792 | 18,447 |
| Gross profit | 44,670 | 42,795 | 43,450 |
| Selling, marketing and administrative expenses | 20,969 | 19,424 | 19,801 |
| Research and development expense | 7,548 | 6,844 | 6,986 |
| Interest income | (91) | (107) | (90) |
| Interest expense, net of portion capitalized (Note 4) | 571 | 455 | 451 |
| Other (income) expense, net | 2,743 | (768) | (526) |
| Restructuring (Note 22) | 569 | 1,073 | |
| Earnings before provision for taxes on income | 12,361 | 16,947 | 15,755 |
| Provision for taxes on income (Note 8) | 2,689 | 3,613 | 3,489 |
| Net earnings | 9,672 | 13,334 | 12,266 |
| Basic net earnings per share (Notes 1 and 15) | 3.54 | 4.85 | 4.45 |
| Diluted net earnings per share (Notes 1 and 15) | 3.49 | 4.78 | 4.40 |
| Cash dividends per share | 2.25 | 2.11 | 1.93 |
| Basic average shares outstanding (Notes 1 and 15) | 2,736,000 | 2,751,400 | 2,759,500 |
| Diluted average shares outstanding (Notes 1 and 15) | 2,775,300 | 2,788,800 | 2,789,100 |
10-K.Info (Beta Test) Courtesy of Short Sands, LLC | |||
JOHNSON & JOHNSON | |||
Ticker: JNJ Fiscal Year: 2011 | |||
Consolidated Statements of Cash Flows | |||
Period Ending Jan 1, 2012 10-K (Filed: Feb 23, 2012) | |||
| (In Millions, except shares in actual) | |||
| 12 Months Ended | 12 Months Ended | 12 Months Ended | |
| Jan 1, 2012 | Jan 2, 2011 | Jan 3, 2010 | |
| Cash flows from operating activities | |||
| Net earnings | $ 9,672 | 13,334 | 12,266 |
| Adjustments to reconcile net earnings to cash flows from operating activities: | |||
| Depreciation and amortization of property and intangibles | 3,158 | 2,939 | 2,774 |
| Stock based compensation | 621 | 614 | 628 |
| Deferred tax provision | (836) | 356 | (436) |
| Accounts receivable allowances | 32 | 12 | 58 |
| Changes in assets and liabilities, net of effects from acquisitions: | |||
| (Increase)/decrease in accounts receivable | (915) | (207) | 453 |
| (Increase)/decrease in inventories | (715) | (196) | 95 |
| Increase/(decrease) in accounts payable and accrued liabilities | 493 | 20 | (507) |
| (Increase)/decrease in other current and non-current assets | (1,625) | (574) | 1,209 |
| Increase in other current and non-current liabilities | 4,413 | 87 | 31 |
| Net cash flows from operating activities | 14,298 | 16,385 | 16,571 |
| Cash flows from investing activities | |||
| Additions to property, plant and equipment | (2,893) | (2,384) | (2,365) |
| Proceeds from the disposal of assets | 1,342 | 524 | 154 |
| Acquisitions, net of cash acquired (Note 20) | (2,797) | (1,269) | (2,470) |
| Purchases of investments | (29,882) | (15,788) | (10,040) |
| Sales of investments | 30,396 | 11,101 | 7,232 |
| Other (primarily intangibles) | (778) | (38) | (109) |
| Net cash used by investing activities | (4,612) | (7,854) | (7,598) |
| Cash flows from financing activities | |||
| Dividends to shareholders | (6,156) | (5,804) | (5,327) |
| Repurchase of common stock | (2,525) | (2,797) | (2,130) |
| Proceeds from short-term debt | 9,729 | 7,874 | 9,484 |
| Retirement of short-term debt | (11,200) | (6,565) | (6,791) |
| Proceeds from long-term debt | 4,470 | 1,118 | 9 |
| Retirement of long-term debt | (16) | (32) | (219) |
| Proceeds from the exercise of stock options/excess tax benefits | 1,246 | 1,226 | 882 |
| Net cash used by financing activities | (4,452) | (4,980) | (4,092) |
| Effect of exchange rate changes on cash and cash equivalents | (47) | (6) | 161 |
| Increase in cash and cash equivalents | 5,187 | 3,545 | 5,042 |
| Cash and cash equivalents, beginning of year (Note 1) | 19,355 | 15,810 | |
| Cash and cash equivalents, end of year (Note 1) | 24,542 | 19,355 | 15,810 |
| Supplemental cash flow data | |||
| Cash paid during the year for: | |||
| Interest | 576 | 491 | 533 |
| Income taxes | 2,970 | 2,442 | 2,363 |
| Supplemental schedule of non-cash investing and financing activities | |||
| Treasury stock issued for employee compensation and stock option plans, net of cash proceeds | 433 | 673 | 541 |
| Conversion of debt | 1 | 1 | 2 |
| Acquisitions | |||
| Fair value of assets acquired | 3,025 | 1,321 | 3,345 |
| Fair value of liabilities assumed and non-controlling interests | (228) | (52) | (875) |
| Net cash paid for acquisitions | 2,797 | 1,269 | 2,470 |
10-K.Info (Beta Test) Courtesy of Short Sands, LLC | ||
JOHNSON & JOHNSON | ||
Ticker: JNJ Fiscal Year: 2011 | ||
Consolidated Balance Sheets | ||
Period Ending Jan 1, 2012 10-K (Filed: Feb 23, 2012) | ||
| (In Millions, except shares in actual) | ||
| As of | As of | |
| Jan 1, 2012 | Jan 2, 2011 | |
| Assets | ||
| Current assets | ||
| Cash and cash equivalents (Notes 1 and 2) | $ 24,542 | 19,355 |
| Marketable securities (Notes 1 and 2) | 7,719 | 8,303 |
| Accounts receivable trade, less allowances for doubtful accounts $361 (2010, $340) | 10,581 | 9,774 |
| Inventories (Notes 1 and 3) | 6,285 | 5,378 |
| Deferred taxes on income (Note 8) | 2,556 | 2,224 |
| Prepaid expenses and other receivables | 2,633 | 2,273 |
| Total current assets | 54,316 | 47,307 |
| Property, plant and equipment, net (Notes 1 and 4) | 14,739 | 14,553 |
| Intangible assets, net (Notes 1 and 5) | 18,138 | 16,716 |
| Goodwill (Notes 1 and 5) | 16,138 | 15,294 |
| Deferred taxes on income (Note 8) | 6,540 | 5,096 |
| Other assets | 3,773 | 3,942 |
| Total assets | 113,644 | 102,908 |
| Liabilities and Shareholders' Equity | ||
| Current liabilities | ||
| Loans and notes payable (Note 7) | 6,658 | 7,617 |
| Accounts payable | 5,725 | 5,623 |
| Accrued liabilities | 4,608 | 4,100 |
| Accrued rebates, returns and promotions | 2,637 | 2,512 |
| Accrued compensation and employee related obligations | 2,329 | 2,642 |
| Accrued taxes on income | 854 | 578 |
| Total current liabilities | 22,811 | 23,072 |
| Long-term debt (Note 7) | 12,969 | 9,156 |
| Deferred taxes on income (Note 8) | 1,800 | 1,447 |
| Employee related obligations (Notes 9 and 10) | 8,353 | 6,087 |
| Other liabilities | 10,631 | 6,567 |
| Total liabilities | 56,564 | 46,329 |
| Shareholders' equity | ||
| Preferred stock - without par value (authorized and unissued 2,000,000 shares) | ||
| Common stock - par value $1.00 per share (Note 12) (authorized 4,320,000,000 shares; issued 3,119,843,000 shares) | 3,120 | 3,120 |
| Accumulated other comprehensive income (Note 13) | (5,632) | (3,531) |
| Retained earnings | 81,251 | 77,773 |
| Shareholders' Equity before deduction of treasury stock | 78,739 | 77,362 |
| Less: common stock held in treasury, at cost (Note 12) (395,480,000 shares and 381,746,000 shares) | 21,659 | 20,783 |
| Total shareholders' equity | 57,080 | 56,579 |
| Total liabilities and shareholders' equity | 113,644 | 102,908 |
| External Links | |
| JOHNSON & JOHNSON (JNJ) Fiscal Year 2011 | |
| Statements of 10-K in Excel | https://www.sec.gov/.../Financial.xlxs |
| Complete 10-K in HTML | https://www.sec.gov/.../10-K.html |
| Complete 10-K in XBRL | https://www.sec.gov/.../10-K-xbrl.zip |